Asset Dedication LLC’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-47
Closed -$590 1180
2024
Q3
$590 Hold
47
﹤0.01% 1093
2024
Q2
$400 Hold
47
﹤0.01% 1146
2024
Q1
$0 Hold
47
﹤0.01% 1058
2023
Q4
$0 Hold
47
﹤0.01% 1071
2023
Q3
$0 Hold
47
﹤0.01% 1081
2023
Q2
$0 Hold
47
﹤0.01% 1053
2023
Q1
$0 Hold
47
﹤0.01% 1095
2022
Q4
$0 Buy
+47
New +$330 ﹤0.01% 1145
2022
Q3
Sell
-47
Closed 1019
2022
Q2
$0 Hold
47
﹤0.01% 1029
2022
Q1
$0 Hold
47
﹤0.01% 1063
2021
Q4
$1K Hold
47
﹤0.01% 906
2021
Q3
$1K Hold
47
﹤0.01% 988
2021
Q2
$2K Buy
+47
New +$1.49K ﹤0.01% 801
2021
Q1
Sell
-47
Closed -$2K 797
2020
Q4
$2K Hold
47
﹤0.01% 724
2020
Q3
$2K Buy
+47
New +$1.61K ﹤0.01% 702

Other funds holding ZYME

Asset Dedication LLC's ZYME Position: Q4 2024 in Review

Asset Dedication LLC sold out of Zymeworks (ZYME) in Q4 2024, closing a stake of 47 shares — an estimated $590 sold.

Asset Dedication LLC first reported a position in ZYME in Q3 2020 and held it in 15 quarters. The position peaked at $2K in Q2 2021. 172 funds tracked by Wall St. Rank hold ZYME as of Q4 2024.

  • Asset Dedication LLC reported no remaining Zymeworks position as of Q4 2024 after selling out during the quarter.
  • Asset Dedication LLC sold 47 Zymeworks shares in Q4 2024, an estimated $590.
  • Asset Dedication LLC first reported a position in Zymeworks in Q3 2020 and held it in 15 quarters.
  • Asset Dedication LLC's Zymeworks position peaked at $2K in Q2 2021.
  • 172 funds tracked by Wall St. Rank held Zymeworks as of Q4 2024.

Based on Asset Dedication LLC's 13F filing for Q4 2024, filed 23 Jan 2025.